泰国患者新诊断心力衰竭的现实世界临床负担
Thanita Boonyapiphat1, Thidaporn Tangkittikasem2, Artit Torpongpun3
1Lampang Hospital, Mueang, Lampang, Thailand.
Cardiology and therapy
|May 6, 2024
概括
泰国新诊断的心力衰竭 (HF) 患者的住院和死亡率较高. 改善护理质量至关重要,以减少该国心力衰竭 (HF) 的负担.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 关于泰国新诊断的心力衰竭 (HF) 负担的数据有限.
- 了解患者人口统计,住院,再住院,死亡率和护理质量是必不可少的.
研究的目的:
- 综合评估泰国新诊断心力衰竭 (HF) 患者的住院,再住院,死亡率,人口统计,特征和护理质量.
主要方法:
- 在2018-2019年期间,对新诊断出HF (ICD-10代码I50) 的成年患者的医疗记录进行了回顾性审查.
- 从五家医院收集的数据.
- 用于分析医院负担和临床结果的描述性统计数据.
主要成果:
- 1134名患者被新诊断为HF,分为HF减少喷射分数 (HFrEF),HF保存喷射分数 (HFpEF) 和HF轻微减少喷射分数 (HFmrEF).
- 平均年龄为66.0岁;再住院率在1年内增加到0.5.
- 总体死亡率为9.8%,心血管死亡率为8.5%,只有很小一部分接受了指导方针导向医学治疗 (GDMT).
结论:
- 与国际研究相比,在泰国新诊断的HF患者表现出更高的特征,住院率和住院死亡率.
- 迫切需要提高护理质量,以减轻泰国的心力衰竭 (HF) 发病率和死亡率.
更多相关视频
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.8K
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
400
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: Diuretics
367
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
367
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inotropic Agents
573
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
573
